| Chr | chr9 |
| start | 21994778 |
| end | 22121097 |
| lncRNA name | ANRIL |
| entrez id | 100048912 |
| hgnc id | HGNC:34341 |
| ensg id | ENSG00000240498 |
| refseq id | NR_003529 |
| methods | qPCR etc. |
| regulated | up-regulated |
| function description | In a series of 12 breast tumor tissues showing a wide range of p14/ARF, p16/ CDKN2A, and p15/CDKN2B mRNA levels, we also observed a stronger positive correlation of ANRIL with p14/ARF than with p16/ CDKN2A or p15/CDKN2B. This study points to the existence of a new gene within the p15/CDKN2B-p16/CDKN2A-p14/ARF locus putatively involved in melanoma-NST syndrome families and in melanoma-prone families with no identified p16/CDKN2A mutations as well as in somatic tumors. |
| pubmed id | 17440112 |
| year | 2007 |
| title | Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. |
| drug | X |
| circulating | X |
| survival | X |
CopyRight © University of Miami, USA; Harbin Medical University, China